JW Therapeutics
Shanghai
About JW Therapeutics
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to save the lives of cancer patients and improve the quality of life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $190.0M
- Funding stage: IPO
- Last round: Series B (Jun 2020)
- Ticker: hkg:2126
- Website: jwtherapeutics.com
- Phone: + 86-21-50464201
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/jw-therapeutics-211909 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.